相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
Vlad Ratziu et al.
GASTROENTEROLOGY (2023)
The Nuclear Receptor PXR in Chronic Liver Disease
Katia Sayaf et al.
CELLS (2022)
A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease
Danae Stella Zareifi et al.
ISCIENCE (2022)
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
He-ming Huang et al.
ACTA PHARMACOLOGICA SINICA (2022)
Effects of Statin Use on the Development and Progression of Nonalcoholic Fatty Liver Disease: A Nationwide Nested Case-Control Study
Jung Il Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Human biomimetic liver microphysiology systems in drug development and precision medicine
Albert Gough et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS)
Courtney Sakolish et al.
TOXICOLOGY (2021)
Echinatin effectively protects against NLRP3 inflammasome driven diseases by targeting HSP90
Guang Xu et al.
JCI INSIGHT (2021)
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba et al.
CELL (2021)
Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors
Manush Saydmohammed et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic liver disease
Hong Yang et al.
ISCIENCE (2021)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Characterization of the immune cell landscape of patients with NAFLD
Tom Diedrich et al.
PLOS ONE (2020)
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
Panu K. Luukkonen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Obeticholic acid for the treatment of nonalcoholic steatohepatitis
Raj A. Shah et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature
Mikiko Watanabe et al.
OBESITY REVIEWS (2020)
A Microphysiological System for Studying Nonalcoholic Steatohepatitis
Tomasz Kostrzewski et al.
HEPATOLOGY COMMUNICATIONS (2020)
Applications of the microphysiology systems database for experimental ADME-Tox and disease models
Mark Schurdak et al.
LAB ON A CHIP (2020)
Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance
Solji Lee et al.
BIOMATERIALS (2019)
Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Antonio Sircana et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Modeling the Effect of the Metastatic Microenvironment on Phenotypes Conferred by Estrogen Receptor Mutations Using a Human Liver Microphysiological System
Mark T. Miedel et al.
SCIENTIFIC REPORTS (2019)
Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism
Alexandra Collin de I'Hortet et al.
CELL METABOLISM (2019)
Network Modeling Approaches and Applications to Unravelling Non-Alcoholic Fatty Liver Disease
Montgomery Blencowe et al.
GENES (2019)
The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis
Edith Hintermann et al.
CELLS (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation
Zobair M. Younossi et al.
TRANSPLANTATION (2019)
Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver
Ting-Ting Li et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD
Zhujun Cheng et al.
MOLECULAR OMICS (2019)
Ensembl 2018
Daniel R. Zerbino et al.
NUCLEIC ACIDS RESEARCH (2018)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling
Lindsey Kennedy et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
Zobair M. Younossi et al.
CLINICS IN LIVER DISEASE (2018)
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Ji-nian Wang et al.
GENE (2018)
Nonalcoholic Fatty Liver Disease: Is It Time for Combination Treatment and a Diabetes-Like Approach?
Stergios A. Polyzos et al.
HEPATOLOGY (2018)
Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome
Mina Kim et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Systems biology in hepatology: approaches and applications
Adil Mardinoglu et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX
Xiang Li et al.
LAB ON A CHIP (2018)
The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease
Michael Doumas et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Changyu Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes
Glenn S. Gerhard et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems
Felipe T. Lee-Montiel et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling
Bin Chen et al.
GASTROENTEROLOGY (2017)
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
Benjamin Wooden et al.
GASTROENTEROLOGY (2017)
PXR: More Than Just a Master Xenobiotic Receptor
Peter O. Oladimeji et al.
MOLECULAR PHARMACOLOGY (2017)
Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
Xue-Ke Zhao et al.
SCIENTIFIC REPORTS (2017)
Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis A Meta-analysis
Giovanni Musso et al.
JAMA INTERNAL MEDICINE (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
A human liver microphysiology platform for investigating physiology, drug safety, and disease models
Lawrence A. Vernetti et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Timothy Hardy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Nuclear receptors and nonalcoholic fatty liver diseases
Matthew C. Cave et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Network-based in silico drug efficacy screening
Emre Guney et al.
NATURE COMMUNICATIONS (2016)
A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine
Andrew M. Stern et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Treatment of Obesity with Celastrol
Junli Liu et al.
CELL (2015)
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Jessica Bazick et al.
DIABETES CARE (2015)
Altered Hepatic Gene Expression in Nonalcoholic Fatty Liver Disease Is Associated With Lower Hepatic n-3 and n-6 Polyunsaturated Fatty Acids
Bianca M. Arendt et al.
HEPATOLOGY (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
Ki Cheong Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
Markus Ahrens et al.
CELL METABOLISM (2013)
Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease
Susan K. Murphy et al.
GASTROENTEROLOGY (2013)
Molecular Interactions between NAFLD and Xenobiotic Metabolism
Adviti Naik et al.
Frontiers in Genetics (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
Prakash Ramachandran et al.
JOURNAL OF HEPATOLOGY (2012)
Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet
Hironori Nakagami et al.
MOLECULAR MEDICINE REPORTS (2012)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Oxandrolone enhances hepatic ketogenesis in adult men
Gloria Lena Vega et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
Cluster-wise assessment of cluster stability
Christian Hennig
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2007)
Capturing heterogeneity in gene expression studies by surrogate variable analysis
Jeffrey T. Leek et al.
PLOS GENETICS (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
I. A. Leclercq et al.
GUT (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
